Atrial Fibrillation management
Atrial fibrillation (AF) in implantable cardiac device (ICD) patients is correlated with…
Multiple independent, real-world analyses demonstrate that atrial fibrillation is common in single-chamber ICD patients.4,5
Single chamber ICDs with a regular ventricular lead, have been unable to determine whether a patient is experiencing AF episodes due to the lack of an atrial lead.
With the TruAF™ Detection Algorithm, you can detect AF without an atrial lead.
How it works
Atrial Fibrillation (AF) can spontaneously organise to slower and/or more organised atrial rhythms. The Reactive ATP™ (rATP) algorithm delivers atrial antitachycardia pacing (ATP) to terminate an ongoing atrial fibrillation (AF) episode.
36% relative reduction in progression to persistent AF.
Reactive ATPTM real-world analysis (n=8,032)6 confirms MINERVA clinical study findings*7
Reactive ATP reduces the incidence of AT/AF6:
References
1
Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. October 1, 2002;113(5):359-364.
2
Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. August 1991; 22 (8):983-988.
3
Boriani G, Glotzer TV, Ziegler PD, et al. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. Heart Rhythm. March 2018;15(3):376-383.
4
Boriani G, et al. Understanding the incidence of AF in single-chamber ICD patients: a real-world analysis. Presented at Europace 2017.
5
Brown ML, et al. New AF Occurrence in Single-Chamber ICD Patients: Insights from a Real-World Investigation. Presented at HRS 2018.
6
Crossley GH, et al. Pacing Clin Electrophysiol. 2019;42:970-979.
7
Boriani G, et al. Eur H eart J. 2014;35:2352-2362.
* Compared to matched control group.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu
For applicable products, consult instructions for use on manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.